GLEEVEC
Novartis AG
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78056665 |
| Registration Number | 2675047 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Attorney Docket Number | 51653 |
| Law Office Assigned | M10 |
| Employee Name | MIZELLE HOWARD, DEZMON |
Timeline
| 2001-04-04 | Application Filed |
| 2001-05-11 | Date of First Use |
| 2002-10-22 | Published for Opposition |
| 2003-01-14 | Trademark Registered |
| 2012-12-08 | Location: GENERIC WEB UPDATE |
| 2012-12-08 | Status: Live/Registered |
| 2013-01-14 | Renewal Date |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novartis AG |
| Address | CH-4002 Basel CH |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations, for use in the field of oncology, namely, for the treatment of cancer |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2001-08-09 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 2001-08-13 | 2 CNRT F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-02-15 | 3 CRFA I:Incoming Correspondence |
| USE AMENDMENT FILED | 2002-02-13 | 4 IUAF S: |
| AMENDMENT TO USE PROCESSING COMPLETE | 2002-06-06 | 5 AUPC I:Incoming Correspondence |
| USE AMENDMENT ACCEPTED | 2002-08-07 | 6 IUAA P: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2002-08-07 | 7 CNSA O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2002-10-02 | 8 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2002-10-22 | 9 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2003-01-14 | 10 R.PR A:Allowance for Publication |
| PAPER RECEIVED | 2004-12-06 | 11 MAIL I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2004-12-19 | 12 TCCA I:Incoming Correspondence |
| CASE FILE IN TICRS | 2008-01-16 | 13 CFIT O:Outgoing Correspondence |
| TEAS SECTION 8 & 15 RECEIVED | 2008-02-14 | 14 E815 I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2008-02-19 | 15 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2008-02-20 | 16 C15A O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-06-18 | 17 TCCA I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2012-11-12 | 18 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2012-12-08 | 19 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2012-12-08 | 20 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2012-12-08 | 21 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2012-12-08 | 22 NA89 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2022-01-14 | 23 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2022-11-18 | 24 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-06-15 | 25 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2023-06-21 | 26 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | 2023-06-21 | 27 RNL2 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2023-06-21 | 28 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GLEEVEC 78478393 3238831 Live/Registered |
Novartis AG 2004-09-03 |
 GLEEVEC 78056665 2675047 Live/Registered |
Novartis AG 2001-04-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 